Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Rund 40 Mio. USD Staatsaufträge bis Juni 2029 gebucht: Jetzt zählt die Marge!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JCLA | ISIN: FR0010609263 | Ticker: 1MK
Frankfurt
19.11.26 | 08:02
0,077 Euro
-1,28 % -0,001
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
MAUNA KEA TECHNOLOGIES Chart 1 Jahr
5-Tage-Chart
MAUNA KEA TECHNOLOGIES 5-Tage-Chart
RealtimeGeldBriefZeit
0,0830,09516:39

Aktuelle News zur MAUNA KEA TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
Zeit Aktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12.11.Mauna Kea Technologies: Pancreatic Cancer Awareness Month: Understanding Cellvizio in Clinical Practice450Regulatory News: Dear Shareholders and Investors, November is Pancreatic Cancer Awareness Month. It highlights a major public health challenge that concerns us all: with the widespread use of...
► Artikel lesen
09.11.Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital350Article L233-8-II of the Commercial Code Article 223-16 of the General Regulations of the AMF Regulatory News: Mauna Kea Technologies (Paris:ALMKT): Listing: Euronext Growth Paris ISIN...
► Artikel lesen
04.11.Mauna Kea Technologies Announces the Launch of CellTolerance at Cleveland Clinic Abu Dhabi, the First Hospital in the MENA Region to Offer the Program451Cleveland Clinic Abu Dhabi is ranked #1 for gastroenterology in the Middle East1 A highly promising commercial roll-out that provides access to one of the world's highest-prevalence Irritable...
► Artikel lesen
20.10.Mauna Kea Technologies Reports Nine-Month 2026 Sales of €4.4 Million, Up 24% at Constant Exchange Rates442Nine-month sales of €4.4 million, up 21% as reported and 24% at constant exchange rates (CER) Europe and Rest of World up 128%, led by CellTolerance, now present in 9 countries with 27 paying...
► Artikel lesen
08.10.Mauna Kea Technologies Announces 2026 Half-Year Results589Product and service revenue of €3.2 million, up 37% driven by strong CellTolerance momentum in Europe and new international markets Gross margin on product and service revenue of 65%, up 2 points...
► Artikel lesen
06.10.Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital477Article L233-8-II of the Commercial Code Article 223-16 of the General Regulations of the AMF Regulatory News: Mauna Kea Technologies (Paris:ALMKT): Listing: Euronext Growth Paris ISIN...
► Artikel lesen
07.09.Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital476Article L233-8-II of the Commercial Code Article 223-16 of the General Regulations of the AMF Regulatory News: Mauna Kea Technologies (Paris:ALMKT): Listing: Euronext Growth Paris ISIN...
► Artikel lesen
26.08.Mauna Kea Technologies Announces Publication of a Landmark Systematic Review and Meta-Analysis Reinforcing the Diagnostic Accuracy and Clinical Impact of Cellvizio in Upper Gastrointestinal Cancer589Largest ever meta-analysis of upper gastrointestinal endomicroscopy pooling 33 studies and 2,350 patients Original research conducted and funded by Korea's National Evidence-Based Healthcare...
► Artikel lesen
MAUNA KEA TECHNOLOGIES Aktie jetzt für 0€ handeln
07.08.Mauna Kea Technologies: Monthly information regarding the total number of voting rights and shares comprising the share capital604Article L233-8-II of the Commercial Code Article 223-16 of the General Regulations of the AMF Regulatory News: Mauna Kea Technologies (Paris:ALMKT): Listing: Euronext Growth Paris ISIN...
► Artikel lesen
28.07.Mauna Kea Technologies Announces Two New Peer-Reviewed Clinical Studies Confirming the Clinical Value of Cellvizio and Its Combination with AI for the Diagnosis of Pancreatic Cysts593International interobserver study confirms increase of diagnostic accuracy to 96% for mucinous vs. non-mucinous, and higher physician agreement with Cellvizio AI Cellvizio increases accuracy...
► Artikel lesen
21.07.Mauna Kea Technologies Reports Strong H1 2026 Core Sales Growth560H1 2026 sales reached €3,203K, up +44% at constant exchange rates (CER) and +39% as reported1 CellTolerance sales increased +145% to €0.9 million, driven by strong international expansion Strong...
► Artikel lesen
16.07.Mauna Kea Technologies to Host a Webinar on July 21, 2026 To Discuss Its First-Half Business Activity492Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, announces...
► Artikel lesen
16.07.Mauna Kea Technologies Secures €4 Million Optional Shareholder Loan To Support Commercial Expansion2
15.07.Mauna Kea Technologies Secures €4.0M Shareholder Loan Agreement to Strengthen Liquidity and Fund Organic Growth793Shareholder loan agreement with long-term financial partner Vester Finance provides Mauna Kea with the contractual option to draw funds, with no obligation to do so, over the next 24 months Financing...
► Artikel lesen
06.07.Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital407Article L233-8-II of the Commercial Code Article 223-16 of the General Regulations of the AMF Regulatory News: Mauna Kea Technologies (Paris:ALMKT): Listing: Euronext Growth Paris ISIN...
► Artikel lesen
04.06.Mauna Kea Technologies Announces the Results of its Combined General Meeting of June 4, 2026539All resolutions recommended by the Board of Directors were adopted, with the exception of the 15th Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio,...
► Artikel lesen
03.06.Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital491Article L233-8-II of the Commercial Code Article 223-16 of the General Regulations of the AMF Regulatory News: Mauna Kea Technologies (Paris:ALMKT): Listing: Euronext Growth Paris ISIN...
► Artikel lesen
03.06.Mauna Kea Technologies Announces New Publication in the UEG Journal Identifying "Triple Healing", a Cellvizio- Assessed Therapeutic Target Associated with Sustained Remission in Ulcerative Colitis428100% of patients achieving Cellvizio-assessed triple healing remained relapse-free over 24 months (0 of 29), versus a ~33% relapse rate among those who did not A decade of converging, multi-center...
► Artikel lesen
20.05.Mauna Kea Technologies Expands Presence in the Middle East with UAE and Turkey Regulatory Approvals and First CellTolerance Commercial Installation573IBS-related symptom prevalence in the region is among the highest in the world, reaching an average of 27% An ideal region uniquely positioned for CellTolerance's direct out-of-pocket commercial...
► Artikel lesen
18.05.Mauna Kea Technologies Announces Nomination of 3 New Directors692Their recognized expertise will help accelerate the strategic transformation launched in 2025 Subject to approval at upcoming Annual General Meeting Regulatory News: Mauna Kea Technologies...
► Artikel lesen
1 2 Weiter >>
38 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1